Results 41 to 50 of about 1,297,078 (335)

PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response. [PDF]

open access: yes, 2016
PurposeThe purpose of our study is to determine if there is a relationship between dose deposition measured by PET/MRI and individual lesion response to yttrium-90 ((90)Y) microsphere radioembolization.Materials and methods26 patients undergoing lobar ...
Fowler, Kathryn J   +7 more
core   +2 more sources

Initial Approach to the Cellular Irradiation Injury of Human Pancreatic Carcinoma Cell Line MIA PaCa-2 by High Dose per Fraction

open access: yesCancer Biology & Medicine, 2010
OBJECTIVE To investigate an initial approach of radiotherapy, which produces cellular radiation injury by high dose in one fraction. METHODS Human pancreatic carcinoma cell line MIA PaCa-2, was cultivated and divided into 5 groups: 0, 2, 5, 10, 17 ...
Ping WANG   +3 more
doaj   +1 more source

Model Selection versus Model Averaging in Dose Finding Studies [PDF]

open access: yes, 2015
Phase II dose finding studies in clinical drug development are typically conducted to adequately characterize the dose response relationship of a new drug.
Bornkamp, Björn   +3 more
core   +2 more sources

Preclinical Evaluation of Botulinum Toxin Type E (TrenibotulinumtoxinE) Using the Mouse Digit Abduction Score (DAS) Assay

open access: yesToxins
TrenibotulinumtoxinE (trenibotE), a botulinum neurotoxin serotype E (BoNT/E), is being developed for clinical use, and can fill a unique treatment gap for patients who are seeking neurotoxin treatment with a rapid onset and short duration of effect. This
Gregory S. Nicholson   +5 more
doaj   +1 more source

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe

open access: yesFrontiers in Pharmacology, 2021
Aims: Cardiovascular outcome trials with anti-diabetic drugs suggest that additional cardiovascular benefit can be achieved independent of improving glycaemic control.
Jeroen V. Koomen   +7 more
doaj   +1 more source

The relationship between zinc intake and serum/plasma zinc concentration in adults: a systematic review and dose–response meta-analysis by the EURRECA Network [PDF]

open access: yes, 2012
Dietary zinc recommendations vary widely across Europe due to the heterogeneity of pproaches used by expert panels. Under the EURRECA consortium a protocol was designed to systematically review and undertake meta-analyses of research data to create a ...
Anna-Louise Stammers   +9 more
core   +2 more sources

Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients

open access: yesRevista do Colégio Brasileiro de Cirurgiões
Objective: to determine the ED90 (minimum effective dose in 90% of patients) of sugammadex for the reversal of rocuronium-induced moderate neuromuscular blockade (NMB) in patients with grade III obesity undergoing bariatric surgery.
MAURO PRADO DA SILVA   +5 more
doaj   +1 more source

The association between perceived stress and mortality among people with multimorbidity: a prospective population-based cohort study [PDF]

open access: yes, 2016
Multimorbidity is common and is associated with poor mental health and high mortality. Nevertheless, no studies have evaluated whether mental health may affect the survival of people with multimorbidity.
Christensen, Kaj Sparle   +8 more
core   +1 more source

Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules

open access: yes, 2020
Recently, phase II trials with multiple schedules (frequency of administrations) have become more popular, for instance in the development of treatments for atopic dermatitis.
Friede, Tim   +2 more
core   +1 more source

Systematic evaluation of pembrolizumab dosing in patients with advanced non-small cell lung cancer [PDF]

open access: yes, 2016
International audienceBACKGROUND: In the phase I KEYNOTE-001 study, pembrolizumab demonstrated durable antitumor activity in patients with advanced non-small cell lung cancer (NSCLC). We sought to characterize the relationship between pembrolizumab dose,
Ahamadi, M.   +22 more
core   +2 more sources

Home - About - Disclaimer - Privacy